PURPOSE: To investigate the value of ultrasonographic (US) features in thyroid nodules with initially benign cytologic results. MATERIALS AND METHODS: The institutional review board approved this retrospective study and required neither patient approval nor informed consent for the review of images and records. From October 2003 to February 2006, 6118 focal thyroid nodules in 6025 consecutive patients underwent US-guided fine-needle aspiration biopsy (FNAB). This study included 1343 nodules 1 cm or larger in 1302 patients that were diagnosed as benign at initial cytologic evaluation and underwent pathologic or follow-up study. We compared the risk of malignancy according to US findings and calculated the likelihoods of different subgroups having benign nodules. RESULTS: In total, 26 (1.9%) malignant and 1317 (98.1%) benign nodules were found according to reference standards. If initial cytologic results showed benign thyroid nodules, the likelihood of the nodule actually being benign was 98.1%. When a thyroid nodule had benign results at both initial and repeat FNAB, the likelihood increased to 100%. The likelihood of having a benign thyroid nodule with suspicious US features was lower (79.6%) than having a benign thyroid nodule with negative US features (99.4%, P<.001). In the nodule with benign features at initial US, the risk of malignancy for a thyroid nodule with an increase in size at follow-up US was slightly higher (1.4%) than that of a thyroid nodule with no interval change or decrease in size, but it was not significantly different (0.5%, P = .354). CONCLUSION: Repeat FNAB should be performed for thyroid nodules that have suspicious US features, even if the initial cytologic results indicate that it is a benign lesion.
PURPOSE: To investigate the value of ultrasonographic (US) features in thyroid nodules with initially benign cytologic results. MATERIALS AND METHODS: The institutional review board approved this retrospective study and required neither patient approval nor informed consent for the review of images and records. From October 2003 to February 2006, 6118 focal thyroid nodules in 6025 consecutive patients underwent US-guided fine-needle aspiration biopsy (FNAB). This study included 1343 nodules 1 cm or larger in 1302 patients that were diagnosed as benign at initial cytologic evaluation and underwent pathologic or follow-up study. We compared the risk of malignancy according to US findings and calculated the likelihoods of different subgroups having benign nodules. RESULTS: In total, 26 (1.9%) malignant and 1317 (98.1%) benign nodules were found according to reference standards. If initial cytologic results showed benign thyroid nodules, the likelihood of the nodule actually being benign was 98.1%. When a thyroid nodule had benign results at both initial and repeat FNAB, the likelihood increased to 100%. The likelihood of having a benign thyroid nodule with suspicious US features was lower (79.6%) than having a benign thyroid nodule with negative US features (99.4%, P<.001). In the nodule with benign features at initial US, the risk of malignancy for a thyroid nodule with an increase in size at follow-up US was slightly higher (1.4%) than that of a thyroid nodule with no interval change or decrease in size, but it was not significantly different (0.5%, P = .354). CONCLUSION: Repeat FNAB should be performed for thyroid nodules that have suspicious US features, even if the initial cytologic results indicate that it is a benign lesion.
Authors: Frederico F R Maia; Patrícia S Matos; Elizabeth J Pavin; José Vassallo; Denise E Zantut-Wittmann Journal: Endocrine Date: 2011-04-16 Impact factor: 3.633
Authors: Xiaoyun Liu; Lijun Zhu; Zhixiao Wang; Dai Cui; Huanhuan Chen; Ling Wei; Yunsong Wu; Rong Rong; Yan Wu; Qing Yao; Zhihong Zhang; Edmund S Cibas; Erik K Alexander; Tao Yang Journal: Mol Clin Oncol Date: 2015-01-22
Authors: Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky Journal: Thyroid Date: 2016-01 Impact factor: 6.568
Authors: Su Min Ha; Jung Hwan Baek; Young Jun Choi; Sae Rom Chung; Tae Yon Sung; Tae Yong Kim; Jeong Hyun Lee Journal: Eur Radiol Date: 2018-06-19 Impact factor: 5.315
Authors: Trevor E Angell; Mary C Frates; Marco Medici; Xiaoyun Liu; Norra Kwong; Edmund S Cibas; Matthew I Kim; Ellen Marqusee Journal: J Clin Endocrinol Metab Date: 2015-09-09 Impact factor: 5.958
Authors: Christine E Cherella; Henry A Feldman; Monica Hollowell; Danielle M Richman; Edmund S Cibas; Jessica R Smith; Trevor E Angell; Zhihong Wang; Erik K Alexander; Ari J Wassner Journal: J Clin Endocrinol Metab Date: 2018-09-01 Impact factor: 5.958